SEC 13F Intelligence

Stenham Asset Management Ltd / UTH

Stenham Asset Management Ltd’s United Therapeutics Corp Del Position

Does Stenham Asset Management Ltd own United Therapeutics Corp Del (UTH)? Not currently — the last reported position was 19.3K shares worth $4M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q4 2021
Shares
19.3K
% of Portfolio
+2.72%
Quarters Held
3
position exited

Position History UTH

Reported value by quarter
Q2 ’21: $3MQ2 ’21Q3 ’21: $4MQ3 ’21Q4 ’21: $4MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202119.3K$4M+2.72%
Q3 202119.3K$4M+2.32%
Q2 202119.3K$3M+2.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stenham Asset Management Ltd’s full portfolio or all institutional holders of UTH.